BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7511132)

  • 21. Modulation of glycine responses by dihydropyridines and verapamil in rat spinal neurons.
    Chesnoy-Marchais D; Cathala L
    Eur J Neurosci; 2001 Jun; 13(12):2195-204. PubMed ID: 11454022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of chronic administration of U-50,488H, a kappa-opioid receptor agonist, on central dopamine D2 receptors of the rat.
    Veeranna ; Reddy PL; Bhargava HN
    Eur J Pharmacol; 1993 Apr; 235(1):23-30. PubMed ID: 8390939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of spinal kappa opioid receptors in the blockade of the development of antinociceptive tolerance to morphine.
    Takahashi M; Senda T; Kaneto H
    Eur J Pharmacol; 1991 Aug; 200(2-3):293-7. PubMed ID: 1664330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists.
    Zahradníková A; Minarovic I; Zahradník I
    J Pharmacol Exp Ther; 2007 Aug; 322(2):638-45. PubMed ID: 17475903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Similar actions of kappa and mu agonists on spinal nociceptive reflexes in rats and their reversibility by naloxone.
    Parsons CG; West DC; Headley PM
    NIDA Res Monogr; 1986; 75():461-4. PubMed ID: 2828992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antinociception produced by receptor selective opioids: modulation of spinal antinociceptive effects by supraspinal opioids.
    Miaskowski C; Levine JD
    Brain Res; 1992 Nov; 595(1):32-8. PubMed ID: 1334770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of [3H]serotonin release by dihydropyridines in spinal cord synaptosomes.
    Gandhi VC; Jones DJ
    Eur J Pharmacol; 1990 Oct; 187(2):271-80. PubMed ID: 1703081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. κ-opioid receptor activation prevents against arrhythmias by preserving Cx43 protein via alleviation of intracellular calcium.
    Shi QX; Zhang LJ; Yao Y; Zhang QY; Wang W; Li J; Shang YL; Bi H; Zhang SM; Guo HT; Wang YM; Yu SQ; Yi DH; Bueno FR; Kaye AD; Pei JM
    Am J Ther; 2013; 20(5):493-501. PubMed ID: 23011166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord.
    Bhargava HN; Gulati A; Ramarao P
    J Pharmacol Exp Ther; 1989 Oct; 251(1):21-6. PubMed ID: 2552075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of selective and non-selective kappa-opioid receptor agonists on cutaneous C-fibre-evoked responses of rat dorsal horn neurones.
    Knox RJ; Dickenson AH
    Brain Res; 1987 Jul; 415(1):21-9. PubMed ID: 2887243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
    Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
    Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of K+ channel blockers on antinociception induced by alpha 2-adrenoceptor, GABAB and kappa-opioid receptor agonists.
    Ocaña M; Baeyens JM
    Br J Pharmacol; 1993 Nov; 110(3):1049-54. PubMed ID: 7905339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective blockade of spinal reflexes by omega-conotoxin in the isolated spinal cord of the neonatal rat.
    Bell JA
    Neuroscience; 1993 Feb; 52(3):711-6. PubMed ID: 7680794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. kappa-opioid agonist U50488 inhibits P-type Ca2+ channels by two mechanisms.
    Kanemasa T; Asakura K; Ninomiya M
    Brain Res; 1995 Dec; 702(1-2):207-12. PubMed ID: 8846078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of antiepileptic drugs, calcium channel blockers and other compounds on seizures induced by activation of voltage-dependent L calcium channel in DBA/2 mice.
    De Sarro G; Ascioti C; di Paola ED; Vidal MJ; De Sarro A
    Gen Pharmacol; 1992 Nov; 23(6):1205-16. PubMed ID: 1283140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord.
    Machelska H; Labuz D; Przewłocki R; Przewłocka B
    J Pharmacol Exp Ther; 1997 Aug; 282(2):977-84. PubMed ID: 9262366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of N- and L-type calcium channel antagonists on the responses of nociceptive spinal cord neurons to mechanical stimulation of the normal and the inflamed knee joint.
    Neugebauer V; Vanegas H; Nebe J; Rümenapp P; Schaible HG
    J Neurophysiol; 1996 Dec; 76(6):3740-9. PubMed ID: 8985872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opioidergic inhibition of capsaicin-evoked release of glutamate from rat spinal dorsal horn slices.
    Ueda M; Sugimoto K; Oyama T; Kuraishi Y; Satoh M
    Neuropharmacology; 1995 Mar; 34(3):303-8. PubMed ID: 7630485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kappa opiate agonists inhibit Ca2+ influx in rat spinal cord-dorsal root ganglion cocultures. Involvement of a GTP-binding protein.
    Attali B; Saya D; Nah SY; Vogel Z
    J Biol Chem; 1989 Jan; 264(1):347-53. PubMed ID: 2535841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of a kappa-opioid receptor agonist-induced analgesia by L-tyrosine and L-tryptophan.
    Barjavel MJ; Thorat SN; Bhargava HN
    Eur J Pharmacol; 1994 Jun; 258(3):173-8. PubMed ID: 8088353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.